Loading insider details...
Beta
Latest Form 4 (Aug 20, 2026): Exercise/Conversion of 6,283 REGN shares, $2.40M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 6,283 | $2.40M |
| Dec 9, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 3,027 | n/a |
| Dec 18, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax Withholding | 491 | $358.8K |
| Dec 10, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 2,591 | n/a |
| Aug 29, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 228 | $274.7K |
| Feb 12, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 344 | $327.0K |
| Jan 25, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 5,000 | $2.78M |
| Jan 4, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 5,000 | $2.78M |
| Dec 29, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 2,448 | $2.10M |
| Dec 26, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 456 | $384.8K |